Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Stavanger University details research in breast cancer
January 29th, 2009
According to recent research published in the Journal of Surgical Oncology, "Androgen receptor (AR) is relevant for prognostication in breast cancer. Different determination methods and Cutoff levels hamper interpretation and comparisons of studies." "Long-term prognostic evaluation of different AR assays in patients comprising operable breast cancers is scarce. AR wits evaluated in 120 primary tumors using the dextran-coated charcoal method (charc-AR), and quantitative immunohistochemistry (IHC) on whole sections (WS) and tissue microarrays (TMA). Nuclear and cytoplasmic-AR localization wits determined, and the prognostic importance of AR assays was assessed....
Source: Women's Health Weekly (2009-01-29)
|
